The post Solana ETFs Hold Strong Despite 70% Token Price Decline appeared on BitcoinEthereumNews.com. Exchange-traded funds tied to Solana have held on to theirThe post Solana ETFs Hold Strong Despite 70% Token Price Decline appeared on BitcoinEthereumNews.com. Exchange-traded funds tied to Solana have held on to their

Solana ETFs Hold Strong Despite 70% Token Price Decline

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Exchange-traded funds tied to Solana have held on to their early inflows, despite the token having more than halved in price since the funds were launched, which analysts say indicates institutional resilience.

Solana (SOL) is down 57% since Solana ETFs launched in the US in July, but the funds have managed to accumulate $1.5 billion in flows and “not really give any of it up,” Bloomberg ETF analyst Eric Balchunas said on Thursday.

He added that 50% of the inflows to the ETFs are from institutional investors, which Balchunas called a “serious investor base” and a good sign for the future.

Solana ETFs beat Bitcoin on market size basis

Balchunas said that by adjusting Solana’s $50 billion market capitalization to Bitcoin’s (BTC), $1.4 trillion, Solana ETFs have seen the equivalent of $54 billion in net new flows, “which is about DOUBLE where Bitcoin was at the same point.”

Bitcoin had also gained in the months after Bitcoin ETFs were launched, compared to Solana’s price fall, which Balchunas said was “pretty impressive numbers given [the] size and condition of the underlying market.”

Solana ETFs hold on to gains as spot prices tank. Source: Eric Balchunas

Balchunas said that ETFs launching into that kind of market downturn usually make it “near impossible to get inflows.”

“Most wouldn’t even make it to age one or two if they went down 57% in the first six months,” he said. “Solana [is] defying physics here.” 

Related: 3 Solana platforms to shutter following devastating $40M hack

Solana ETFs saw their first net outflow day in over a month on Thursday with $6 million exiting the six products, according to CoinGlass. It followed a big net inflow day on Wednesday when $19 million entered the products. 

Solana down 70% from all-time high

Solana hit an all-time high in January 2025 amid a memecoin minting frenzy that pushed the token to $293.

Today, it is 70% down from that peak, trading at around $88, having fallen 2.7% on the day and 11% over the past month, according to CoinGecko.

SOL has tanked almost 30% since the beginning of the year. Source: TradingView

Magazine: Would Bitcoin really be at $200K if not for Jane Street? Trade Secrets

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/solana-etfs-impressive-numbers-token-dives-since-launch?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09